OraSure Technologies | OSUR - Loan Capital


OraSure Technologies reported $100K in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.05B 1000K Mar/2026
AngioDynamics USD 5.6M 100K Sep/2025
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 802.9M 398.8M Mar/2026
Bruker USD 1.66B 189.6M Mar/2026
Cerus USD 64.86M 22K Dec/2024
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Danaher USD 17.56B 855M Mar/2026
Dentsply International USD 2.01B 9M Mar/2026
Dexcom USD 1.3B 54.4M Mar/2026
Illumina USD 1.49B 0 Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 13.99B 105M Mar/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Mettler Toledo International USD 2.16B 73.35M Mar/2026
Myriad Genetics USD 120.3M 400K Mar/2026
OraSure Technologies USD 100K 17K Dec/2025
Quidel USD 0 2.47B Mar/2026
Repligen USD 546.58M 4.37M Mar/2026
Revvity USD 2.63B 836K Mar/2026
STAAR Surgical USD 42K 42K Dec/2023
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Trinity Biotech USD 114.86M 4.81M Sep/2025
Waters USD 5.22B 3.81B Mar/2026